Pfizer Inc. is an American multinational pharmaceutical corporation.
翻译：辉瑞公司是一家美国跨国制药企业。
Pfizer developed and produced the first FDA-approved COVID-19 vaccine in partnership with BioNTech.
翻译：辉瑞公司与BioNTech合作研发并生产了首款获得美国食品药品监督管理局（FDA）批准的COVID-19疫苗。
Pfizer's headquarters are located in New York City, United States.
翻译：辉瑞公司的总部位于美国纽约市。
The company
Pfizer has a long history of developing innovative medicines for various diseases.
翻译：辉瑞公司在开发治疗各种疾病的创新药物方面有着悠久的历史。
In 2020,
Pfizer made headlines with its highly effective coronavirus vaccine candidate.
翻译：2020年，辉瑞凭借其高度有效的冠状病毒疫苗候选产品登上了新闻头条。
Pfizer invests heavily in research and development to create breakthrough treatments for patients worldwide.
翻译：辉瑞大力投资于研究和开发，以创造出全球患者所需的突破性治疗方法。
Many of
Pfizer's drugs have become household names, such as Viagra used to treat erectile dysfunction.
翻译：辉瑞公司的许多药品已家喻户晓，如用于治疗勃起功能障碍的伟哥（Viagra）。
Pfizer employs over 80,000 people worldwide across multiple locations and subsidiaries.
翻译：辉瑞在全球各地及其子公司拥有超过8万名员工。
The merger between
Pfizer and Allergan was terminated in 2016 due to new U.S. Treasury rules.
翻译：由于新的美国财政部规定，辉瑞与艾尔建在2016年的合并计划被终止。
Pfizer is committed to improving access to healthcare in underserved communities around the world.
翻译：辉瑞致力于改善世界各地服务不足社区的医疗保健获取情况。
Volkswagen AG's chief executive visited China from late January to early February, the company said, while Apple CEO Tim Cook and Pfizer CEO Albert Bourla are expected to visit next month, people familiar with the matter told the Wall Street Journal.
知情人士告诉《华尔街日报》，大众汽车公司表示，该公司首席执行官于1月底至2月初访问了中国，而苹果首席执行官蒂姆·库克和辉瑞首席执行官阿尔伯特·波拉预计将于下月访问。
Top executives weighing a visit to the China Development Forum in Beijing include Apple CEO Tim Cook and Pfizer CEO Albert Bourla, people familiar with the matterxa0told the journal.
知情人士告诉《华尔街日报》，正在考虑访问北京中国发展高层论坛的高管包括苹果首席执行官蒂姆·库克和辉瑞首席执行官阿尔伯特·波拉。
"Jean-Christophe Pointeau, China president for Pfizer Global Biopharma Business, said the CIIE has proved to be a valuable platform for exhibition and communication to enhance joint efforts to optimize the public health and epidemic prevention system.
辉瑞全球生物制药业务中国区总裁Jean-Christophe Pointeau表示，事实证明，CIIE是一个宝贵的展览和交流平台，可以加强共同努力，优化公共卫生和防疫系统。
During last year's CIIE, Pfizer's antiviral oral therapeutic drug for COVID-19 Paxlovid made its debut in China.
在去年的CIIE期间，辉瑞公司针对新冠肺炎的抗病毒口服治疗药物奈玛特韦片/利托那韦片组合包装首次在中国上市。
The paper, compiled by the special committee, took an in-depth look at six companies - Pfizer, Siemens Healthineers, Johnson & Johnson, Abbott, BioMerieux and PerkinElmer - and how their investments, best practices, innovations, corporate social responsibility and strategic agendas in China can be used as a reference to enhance China's public health system.
这篇由特别委员会汇编的论文深入研究了辉瑞、西门子Healthineers、强生、雅培、BioMerieux和PerkinElmer六家公司，以及它们在中国的投资、最佳实践、创新、企业社会责任和战略议程如何作为加强中国公共卫生系统的参考。
Pfizer, the global biopharmaceutical company, held a launch ceremony for Cibinqo – an oral, once-daily highly selective JAK1 (Janus kinase 1) inhibitor, for treating adult patients with moderate-to-severe atopic dermatitis -- in China on Sunday.
周日，全球生物制药公司辉瑞在中国举行了Cibinqo的上市仪式。Cibinqo是一种口服的、每天一次的高选择性JAK1（Janus激酶1）抑制剂，用于治疗中重度特应性皮炎的成年患者。
Jean-Christophe Pointeau, president of China Pfizer Biopharmaceutical Group, said that Cibinqo is the group's globally ground-breaking innovative product in inflammation and immunology, and a crucial part of its dermatology strategic planning in China.
中国辉瑞生物制药集团总裁Jean-Christophe Pointeau表示，Cibinqo是该集团在炎症和免疫学领域的全球突破性创新产品，也是其在中国皮肤科战略规划的重要组成部分。
The launch of this inhibitor marks a globally synchronized R&D and regulatory application process and Pfizer's second breakthrough in Atopic dermatitis (AD) treatment.
该抑制剂的推出标志着全球同步的研发和监管应用程序，以及辉瑞在特应性皮炎（AD）治疗方面的第二次突破。
By further enriching the AD portfolio, Pfizer is set to meet the full range of treatment needs for AD patients with mild, moderate and severe atopic dermatitis.
通过进一步丰富AD产品组合，辉瑞将满足轻度、中度和重度特应性皮炎AD患者的全方位治疗需求。
As Pfizer's innovative targeted lung cancer therapy, the tablet demonstrates breakthrough in improving patients' progression-free survival, can better penetrate blood-brain barrier, and have less drug resistance, said the company.
辉瑞公司表示，作为其创新的靶向性癌症治疗方案，该片在提高患者无进展生存率方面取得了突破，可以更好地穿透血脑屏障，并减少耐药性。
未经许可，严禁转发。QQ交流群：688169419